NYU Langone patient recovers after world’s 1st face, eye transplant

Fifteen months after undergoing the world’s first whole-eye and partial face transplant at NYU Langone Health, a 46-year-old Arkansas resident has achieved recovery with no episodes of tissue rejection. 

Advertisement

The patient, Aaron James, survived a 7,200-volt electrical accident at work “with catastrophic tissue loss to his face,” according to a study published Sept. 9 in JAMA. On May 27, 2023, more than 140 healthcare workers at NYU Langone performed a 21-hour surgery on Mr. James. 

The transplanted donor eye has maintained normal pressure and blood flow, but vision in that eye has not returned, according to a Sept. 9 news release from the New York City-based system. 

Tests have shown a photoreceptor response, though, indicating the rods and cones survived the transplant — which “[gives] hope for the future of whole-eye transplants with an aim to restore sight,” the release said. 

It was the first procedure to attempt to inject stem cells into a human optic nerve during a transplant, the system said, adding that NYU Langone will turn next to preserving nerve cells in the eye during the transplant process, which might help restore vision.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Patient Safety & Outcomes

  • How many of you have felt like a flea in a jar? If you put fleas in a jar, they…

Advertisement

Comments are closed.